AIDS/IAS Conference
Conference Coverage
Rising viral load on dolutegravir? Investigators try fix before switch
“If you can get through those difficult phases, people can go back on their meds,” he said in an interview. “It’s almost a sociological problem...
Conference Coverage
Results from halted islatravir antiretroviral trial presented
Because of persistent concerns about the impact on CD4+ T cells and total lymphocytes, another phase 3 trial is now underway using a lower 0.25 mg...
Conference Coverage
Injecting long-acting antiretrovirals into clinic care
In the peer staff program, workers are trained in a 4-month medical residency–style program that shows them how to test for HIV, inject long-...
Conference Coverage
UNAIDS targets: Progress reported, but ‘HIV is far from over’
New infections persist at a rate that has not dropped as fast as possible.
Conference Coverage
Low HIV levels linked to ‘almost zero’ risk of sexual transmission
“This [finding] provides a powerful opportunity to help destigmatize HIV, promote the benefits of adhering to antiretroviral therapy, and support...
Conference Coverage
Daily statin cuts cardiovascular risk in HIV
“These are types of people who, if they came to the doctor’s office right now before REPRIEVE, they would largely be told your risk score is not...
Conference Coverage
Injectable HIV prevention better than pills in two trials
“The incredible efficacy of long-acting PrEP for cisgender women shown by HPTN 084 is game-changing for our practice.”
Conference Coverage
Landmark ALLIANCE results offer tenofovir guidance in HIV/HBV coinfection
“There is hardly any good reason to give the two-pill DTG regimen over single-tablet BTG/TAF/FTC in HBV-coinfected people living with HIV.”
Conference Coverage
Doxycycline cuts STI risk in men and trans women having sex with men
“It is time to take action on the data that we have and really think about incorporating it into guidelines and rolling this out in a safe and...
Conference Coverage
Prolonged remission in patient with HIV may open new avenues to functional cure
“This case opens new avenues in the HIV functional-cure field.”
Conference Coverage
Fourth patient cleared of HIV after stem cell transplant for blood cancer
“Although a transplant is not an option for most people with HIV, these cases are still interesting, still inspiring, and help illuminate the...
Conference Coverage
Two-drug dolutegravir treatment noninferior to 3/4 drug regimen
The fixed-dose dolutegravir-based regimen shows noninferiority versus any ART regimens, while also showing feasibility as a first-line treatment...
News
HIV-associated cryptococcal meningitis: Single-dose regimen found non-inferior
Mortality from cryptococcal meningitis with a single-dose regimen of liposomal amphotericin B is similar to the...
Conference Coverage
Twice-a-year lenacapavir shows viral suppression in drug-resistant HIV at 26 weeks
“According to its long half-life of two subcutaneous injections per year, [it] could help reduce pill burden.”
Conference Coverage
HIV: Could another two-drug regimen be on the horizon?